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Health status in COPD cannot be measured by 
the St George's Respiratory Questionnaire alone: 
an evaluation of the underlying concepts of this 
questionnaire
Leonie Daudey ' , Jeannette B Peters ' ,  Johan Molema , PN Richard Dekhuijzen , Judith B Prins ,
Yvonne F Heijdra2, Jan H Vercoulen1,2
Abstract
Background: Improving patients' health status is one of the major goals in COPD treatment. Questionnaires could 
facilitate the guidance of patient-tailored disease management by exploring which aspects of health status are 
problematic, and which aspects are not. Health status consists of four main domains (physiological functioning, 
symptoms, functional impairment, and quality of life), and at least sixteen sub-domains. A prerequisite for patient- 
tailored treatment is a detailed assessment of all these sub-domains. Most questionnaires developed to measure 
health status consist of one or a few subscales and measure merely some aspects of health status. The question 
then rises which aspects of health status are measured by these instruments, and which aspects are not covered. 
As it is one of the most frequently used questionnaires in COPD, we evaluated which aspects of health status are 
measured and which aspects are not measured by the St George's Respiratory Questionnaire (SGRQ).
Methods: One hundred and forty-six outpatients with COPD participated. Correlations were calculated between 
the three sections of the SGRQ and ten sub-domains of the Nijmegen Integral Assessment Framework, covering 
Symptoms, Functional Impairment, and Quality of Life. As the SGRQ was not expected to measure physiological 
functioning, we did not include this main domain in the statistical analyses. Pearson's r > 0.70 was used as criterion 
for conceptual similarity.
Results: The SGRQ sections Symptoms and Total showed conceptual similarity with the sub-domain Subjective 
Symptoms (main domain Symptoms). The sections Activity, Impacts and Total were conceptual similar to Subjective 
Impairment (main domain Functional Impairment). The SGRQ sections were not conceptual similar to other sub­
domains of Symptoms, Functional Impairment, nor to any sub-domain of Quality of Life.
Conclusions: The SGRQ could facilitate the guidance of disease management in COPD only partially. The SGRQ is 
appropriately only for measuring problems in the sub-domains Subjective Symptoms and Subjective Impairment, 
and not for measuring problems in other sub-domains of health status, such as Quality of Life.
Background
COPD is a chronic and debilitating disease and a lead­
ing cause of m orbid ity  and m ortality  w orldw ide [1]. 
According to the latest estimates of the W orld Health 
O rganization (W HO), 210 million people have COPD 
and 3 m illion  people died of COPD in 2005 [2].
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Im proving patien ts ' health  status is one of the m ajor 
goals in COPD treatm ent [3].
Quality of life has become an im portant endpoint in 
medical care, but still there is no consensus on the defi­
nition of these concepts [4]. Smith and colleagues con­
sider quality  of life and health  sta tu s to  be separate 
constructs, in w hich quality of life is m ore related to 
m ental health, whereas health status is more related to 
physical function ing  [4 ]. T he W H O  uses a b roader
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definition of health status, by defining health status as 'a 
state of complete physical, mental and social well-being, 
and no t m erely the absence of disease or infirm ity '. 
Similarly, others [5,6] define health status as an overall 
concept covering physiological functioning, symptoms, 
functional im pairm ent, quality of life, and social func­
tion ing  as im p o rtan t m ain  dom ains. T hese m ain 
dom ains were empirically found to be fu rther divided 
into sixteen sub-domains [7,8], each sub-domain repre­
senting a unique aspect of health status. Despite differ­
ences in defin itions found in the  lite ra tu re  it has 
becom e clear th a t a pa tien t's  functioning consists of 
many conceptually distinct sub-domains. Patient-tailored 
trea tm en t then  requires assessm ent of all these sub ­
domains.
Questionnaires could facilitate the guidance of patient- 
tailored disease management by exploring which aspects 
of health status are problem atic and which aspects are 
not. The past decade m any questionnaires have been 
developed to  m easure health status. However, m ost of 
these instrum en ts consists of only one or a few sub­
scales and thus measure merely some aspects of health 
status. The question then rises which aspects of health 
status are m easured by these instrum ents, and which 
aspects are not covered.
The St George's Respiratory Q uestionnaire (SGRQ), 
for instance, is one of the m ost frequently  used and 
translated disease specific health status instrum ents in 
COPD [9- 11]. A recent Pubm ed search gave 555 hits 
(date 06/03/2010; terms SGRQ and St George's Respira­
tory Questionnaire). The SGRQ has been developed to 
allow com parative m easu rem en t of h ea lth  betw een 
patient populations and to quantify changes in health 
following therapy [12]. The SGRQ consists of three sec­
tions and a total score: Symptoms, m easuring the fre­
quency and severity of respiratory symptoms; Activity, 
measuring limitation of activities by breathlessness and 
activities that cause breathlessness; Impacts, measuring 
disturbances in social and psychological functioning due 
to airway disease; Total score summarizes the impact of 
the disease on overall health status [12-14]. The SGRQ 
thus measures maximally three of the sixteen aspects of 
health status. It is not clear which aspects of health sta­
tus are measured, and which aspects of health status are 
no t m easured  by the SGRQ. This question  is all the 
im portant to unravel, because the SGRQ, as many other 
questionnaires, is subject to conceptual confusion. The 
SGRQ initially was conceived as a standard ized  self­
completed questionnaire for measuring health and per­
ceived well-being ('QoL') in airways diseases [12]. In the 
lite ra tu re , how ever, the SGRQ is in terchangeab ly  
referred to as a m easure of quality of life [15], health- 
related quality of life [16], health status [17], a measure 
for impaired health [18], or a measure of overall impact
of the disease [19]. Different terms are used for the con­
c e p ts )  the  SGRQ m easures. A dditionally , since the 
SGRQ is often used as a criterion in validity testing of 
other instrum ents [20,21], it is essential to clarify which 
aspects of health status the SGRQ measures.
In the present study, we tested which aspects of health 
status are measured by the SGRQ in COPD, by compar­
ing the SGRQ sections Symptoms, Activity and Impacts 
w ith  m ultip le  aspects of the h ealth  sta tu s  dom ains 
Symptoms, Functional Impairment and Quality of Life.
Material and methods
Subjects
The 146 subjects took part on a longitudinal study on 
health  status in COPD. Patients were recru ited  from  
three different ou tpatien t centres in the N etherlands: 
Radboud U niversity N ijm egen M edical C entre, M aas 
H osp ita l Boxm eer, and R ijnstate H osp ita l A rnhem . 
Patients had to fulfil the Global Initiative for Chronic 
O bstructive Lung Disease (GOLD) criteria of a post- 
bronchodilator FEV1% predicted between 30 and 80 per­
cent with a reversibility of obstruction of less than 12% 
[1]. Patients suffering from primary co-morbidity or co­
m orbidity that prevented full adherence to the research 
p ro toco l w ere excluded, as well as pa tien ts  w ith  an 
acute exacerbation, recent (<6 months) participation in 
a rehabilitation program, or who were not able to speak 
or read D utch. O ne-hundred-and-six ty-eight patients 
participated  in this study. After one year, the assess­
m ents were repeated in 146 patients (87% of included 
patients in first part). Reasons for dropout were diverse: 
passed away (N = 5), co-morbidity (N = 3), participation 
in a rehabilitation programme between the first and sec­
ond assessments (N = 2), being too busy (N = 4), found 
participation too exhausting (N = 3), or no transporta­
tion (N = 2). For three patients the reasons for dropout 
were unknown. Data of these 146 patients were used in 
the present study. The inclusion procedure is described 
in more detail elsewhere [7]. The study was approved by 
the M edical Ethics Com m ittee CMO Region A rnhem ­
Nijmegen (P02.1411L; CM O-nr 2002/047). Subjects gave 
informed consent.
Procedures
Subjects visited the Departm ent of Pulmonary Diseases 
twice. Physiological assessm ents were perform ed and 
subjects received the Aktometer (accelerometer measur­
ing actual physical activity) [22]. Two weeks later sub­
jects completed questionnaires by the TestOrganiser, a 
com puter p rogram  developed by the D epartm en t of 
Medical Psychology and the Department of Instrumental 
Services of the Radboud University Nijmegen Medical 
Centre [7]. Questionnaires were presented in the same 
layout as the paper-and-pencil versions, and a simple
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response board enabled subjects with no prior computer 
experience to operate the TestOrganiser easily.
Measurements
Demographic data were recorded. Pulm onary function 
tests were performed, including transfer capacity for car­
bon m onoxide using the Jaeger m asterlab-spirom eter 
according to ERS-criteria [23], and indices of body com­
position (BodyStat 1997).
St George's Respiratory Questionnaire (SGRQ)
The SGRQ consists of 50 items with weighted responses 
divided in th ree  sec tions - Symptoms, Activity, and 
Im pacts - and a Total score [12- 14]. Scores are 
expressed as percentages of the maximally possible sum 
of weights. A score of zero represents no health impair­
ment, a score of 100 means maximal health impairment.
Health status main domains Symptoms, Functional 
Impairment, and Quality of Life
H ealth status was m easured by the Nijmegen Integral 
Assessment Framework (NIAF) [7]. The NIAF provides 
a detailed and empirical definition of health status and 
covers the dom ains Physiological Functioning, Symp­
toms, Functional Impairment, and Quality of Life. These 
four main domains were found to be subdivided into 15 
distinct sub-domains [7]. In another study [8], we found 
that fatigue was an additional sub-domain. Factor ana­
lyses were used to identify underlying concepts in the 
data. Social Functioning did not emerge as a separate 
factor, aspects of social functioning were p art of the 
m ain dom ains Quality of Life and Functional Im pair­
ment. The sub-domains are measured by different exist­
ing instruments, and for each sub-domain a Sub-domain 
Total Score (STS) was calculated. As the SGRQ was not 
expected to  m easure physiological functioning, in this 
study  we only evaluated the ten  sub-dom ains of the 
main domains Symptoms, Functional Im pairm ent, and 
Quality of Life. See Table 1 for definitions of the sub­
domains and corresponding instruments.
Statistical Analyses
The relationships between the sections of the SGRQ and 
the sub-domains of the NIAF, as well as the intercorrela­
tions of the SGRQ sections, were analyzed by Pearson cor­
relation coefficients. To avoid Type I error due to multiple 
testing P was set at 0.01. A Pearson's r > 0.70 was used as 
criterion for conceptual similarity between the sections of 
the SGRQ and the sub-domains of the NIAF [24].
Results
Subjects
The study sample could be characterized as predom i­
nantly  male, low educated, and living w ith a partner
(Table 2). M ost subjects were GOLD II/III patients. 
Some subjects were classified in GOLD I or IV, due to 
norm al variation in FEV1 between the time of the first 
assessment and second assessment one year later.
Conceptual similarity between sections of the SGRQ and 
sub-domains of the NIAF
The SGRQ sections w ere significantly  co rre la ted  to 
many health status aspects, however conceptual similar­
ity (r > 0.70) was only reached for two sub-dom ains of 
the NIAF (Table 3). The SGRQ sections Symptoms and 
Total were conceptual similar to the NIAF sub-domain 
Subjective Sym ptom s (m ain dom ain Symptoms). The 
SGRQ sections Activity, Impacts, and Total were con­
ceptually sim ilar to  the NIAF sub-dom ain Subjective 
Impairment (main domain Functional Impairment).
Intercorrelations of the SGRQ sections
Intercorrelations between the SGRQ sections were m od­
erate  to  high (Table 4 ). T he SGRQ section  Total 
exceeded the criterion of conceptual similarity with all 
SGRQ sections (r > 0.70, p < 0.01). T he correlation  
betw een the sec tions Impacts and Activity  alm ost 
reached the criterion of conceptual similarity (r = 0.69, 
p < 0.01).
Discussion
The present study evaluated which aspects of health sta­
tus are m easured  by the sections of the SGRQ, and 
w hich aspects of health  status are no t covered by the 
SGRQ.
The sections of the SGRQ correlated significantly with 
m ost sub-dom ains of the  NIAF, ind ica ting  th a t the 
SGRQ was related to many health status aspects. How­
ever, m ost correlations were low to m oderate and well 
below 0.70, indicating that shared variance was too low 
to conclude tha t sections of the SGRQ were concep­
tually similar to these sub-domains.
Applying the criterion  of conceptual sim ilarity, the 
SGRQ measured two of the ten evaluated sub-domains 
of hea lth  sta tus. The SGRQ sections Symptoms and 
Total showed conceptual similarity with the sub-domain 
Subjective Sym ptom s (m ain dom ain Sym ptom s), the 
SGRQ sections Activity, Impacts, and Total showed con­
ceptual s im ilarity  w ith  the sub -dom ain  Subjective 
Impairment (main domain Functional Impairment).
In a previous study [7] we found a high correlation 
betw een the sub-dom ains Subjective Im pairm ent and 
Subjective Sym ptom s. T he in s tru m en ts  included  in 
these sub-dom ains were different w ith respect to the 
content of the items, but had in common that the item- 
and-response format required highly subjective and gen­
eral in terpretations by the patient. It was argued that 
both sub-domains measured highly subjective notions of
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Table 1 Main domains Symptoms, Functional Impairment and Quality of Life of the Nijmegen Integral Assessment 
Framework
Sub-domain Definition Instrument (subscales)
Symptoms
Subjective The patient's overall burden o f pulm onary PARS-D: G lo b a lD ysp n ea  Activity, G lo b a lD ysp nea  Burden, Dyspnea
Sym ptom s symptom s Activity [7]; QoLRiQ: Breathing Problems [33]
Dyspnea The le v e lo f  frustration, depressive feelings, and DEQ: Frustration, M ood, Anxiety [7]
Emotions anxiety a person 
experiences w hen dyspnoeic
Expected The le v e lo f  dyspnea that a patients expect to PARS-D: Expected Dyspnea [7]
Dyspnea experience during specific 
activities no longer performed
Fatigue The le v e lo f  experienced fatigue CIS: Subjective fatigue [34]
Functional
Impairment
A ctualPhysica l The a c tu a lp h ys ica lac tiv ity  a patient performs Aktom eter (electronic accelerom eter) [22]
Activity during tw o  weeks
Behavioral The extent to which  a person cannot perform SIP: Body Care &  M ovem ent, H om e M anagem ent, Mobility, Ambulation
Impairment specific and concrete
activities as a result o f having the disease
[35]
Subjective The experienced degree of impairm ent in QoLRiQ: GeneralActiv ities, Socia lA ctiv it ies [33]; G lo ba lIm pa irm en t [7];
Impairment general, and in socia lfunction ing SIP: Socia lIn teraction , Burden [35]
Quality of Life
G enera lQ u ality M ood, anxiety, and the satisfaction o f a person Satisfaction W ith  Life Scale [36] Sym ptom  Check List: Anxiety [37]
of Life w ith his/her life as a w ho le BDI: Primary Care [38]
Health-related Satisfaction related to physio logicalfunctioning Satisfaction Physio log ica lFunction ing , Satisfaction Future [7]
Quality o f Life and the future
Satisfaction Satisfaction w ith the (absent) relationships w ith Satisfaction Spouse, Satisfaction S o c ia l[7]
Relations spouse and others
PARS-D: Physical Activity Rating Scale-Dyspnea; QoLRiQ: Quality of Life for Respiratory Illness Questionnaire; DEQ: Dyspnea Emotions Questionnaire; CIS: Checklist 
Individual Strength; SIP: Sickness Impact Profile; BDI, Beck Depression Inventory
'being ill', also referred to as illness perceptions [25]. As 
the SGRQ reached the criterion for conceptual similarity 
with these two sub-domains, this would imply that the 
SGRQ in fact m easures illness perceptions, related to 
symptoms (section Symptoms and Total) and functional 
impairment (sections Activity and Impacts). This conclu­
sion is underlined by the high intercorrelations between 
the SGRQ sections, some correlations even exceeding 
the criterion for conceptual similarity.
A lthough illness percep tions re la ted  to  sym ptom s 
and functional im pairm ent are very relevant concepts, 
many other im portant aspects of health status are not 
covered by the SGRQ. W ith respect to the SGRQ as a 
m easure of aspects of sym ptom s, these are restricted  
to  the subjectively experienced severity of pulm onary 
symptoms. O ther im portant aspects of symptoms, such 
as dyspnea-related emotions, are not measured specifi­
cally. W ith  respect to functional im pairm ent, only the 
subjectively experienced im pairm ents are m easured by 
the  SGRQ. Im p a irm en t on the behavioural level or 
actual physical activity level is n o t m easured  by the 
SGRQ sections. Furthermore, the present study showed 
that the SGRQ does not measure any of the three sub­
domains of quality of life evaluated in this study (Gen­
eral Quality of Life, Health-related Quality of Life, and
Satisfaction Relation). Finally, since the SGRQ m ea­
sures m erely two sub-dom ains of the  ten  evaluated 
sub-dom ains, the SGRQ does no t provide a detailed 
m easurem ent of health  status. Similarly, p resen t data 
show  th a t the  SGRQ shou ld  be co n sid ered  a valid 
m easure of im paired  health  in COPD, as the SGRQ 
originally was conceived. However, the  SGRQ m ea­
sures only two aspects of im paired health  (subjective 
symptoms and subjective im pairm ent). To measure all 
aspects of im paired  h ea lth , and th ereb y  allow ing 
patient-tailored  treatm ent, o ther instrum ents need to 
be included as well.
Some m ethodological issues need to  be addressed. 
First, the NIAF is no t the definite answer to  the p ro ­
blem of conceptual confusion in current health  status 
instruments. Other aspects of health status not included 
in the fram ework may be relevant to COPD patients. 
This needs to be addressed in future studies, in which 
patient feedback should be incorporated. Nevertheless, 
this framework does provide a much more detailed defi­
n ition of health status, as expressed by the many sub­
dom ains, and is m uch m ore form ula ted  in  te rm s of 
empirical observations than found in the literature. Each 
sub-dom ain represents a (conceptually) unique health 
status aspect. At least 16 sub-domains are m easured to
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Table 2 Demographic, clinical data, and data of the St 
George's Respiratory Questionnaire of participating 
COPD patients
Variable Mean ± SD
M ale sex % 76.7
A ge (years) 65.8 ± 9.0
Education %
Low 48.6
Middle 29.5
High 19.9
Personal situation %
Partner 77.8
Divorced 6.3
W ido w h ood 8.3
Single 7.6
Cigarette smoking %
Current 41.8
Former 45.9
Never 11.0
BM I (kg/m2) 25.9 ± 4.1
FEV1 (L) 1.6 ± 0.5
FEV1 %  predicted 53.6 ± 13.9
FEV1/FVC % 44.0 ± 11.4
TLC %  predicted 103.7 ± 14.6
RV %  predicted 128.3 ± 30.3
TLCO %  predicted 62.3 ± 21.5
G O LD  %
I
II
2.1
58.9
III 34.2
IV 4.8
SGRQ section
Sym ptom s 40.9 ± 24.8
Activity 40.9 ± 21.8
Impacts 20.2 ± 13.5
Total 30.2 ± 15.4
Data are presented as mean ± SD unless otherwise indicated. Percentages 
may not add up to 100 due to missing data (three patients with no specified 
education, two patients with no specified smoking habits). BMI: body mass 
index; FEV1 %  predicted: forced expiratory volume in one second as 
percentage predicted; FEV1 /FVC %: forced expiratory volume/forced vital 
capacity; TLC: total lung capacity; TLC %  predicted: total lung capacity as 
percentage predicted; RV: residual volume; RV: residual volume as percentage 
predicted; TLœ %  predicted: transfer capacity (of lung) for carbon monoxide 
as percentage predicted; GOLD: Global Initiative for Chronic Obstructive Lung 
Disease; SGRQ: St George's Respiratory Questionnaire.
provide a detailed  p ic tu re  of the h ealth  s ta tu s  of a 
COPD patient.
Second, using the criterion of conceptual similarity (r 
> 0.70) as a standard for validity seems a very strict cri­
terion. However, considering the conceptual confusion 
in  h ea lth  sta tus, one m ust be carefully  in te rp re tin g  
results of earlier validity studies. Often, m uch lower cor­
relations are accepted as evidence for the validity of the 
instrum ent under scrutiny. For example, a correlation
between two instruments of 0.40 may be statistically sig­
nificant, but it indicates only 16% of shared variance. 
Unambiguous conclusions concerning conceptual simi­
larity between two instrum ents can only be drawn from 
the results using a strict approach.
The p resen t study  focuses on the re la tionsh ips 
betw een the SGRQ sections and the m ain dom ains 
Symptoms, Functional Impairment, and Quality of Life. 
Therefore, the conclusions of the present study are not 
applicable w ith respect to  physiological functioning. 
However, from a theoretical point of view it is unlikely 
tha t a questionnaire will provide a d irect m easure of 
physiological processes. For example, studies to  date 
[26,27] often show a relationship between FEV1 and the 
SGRQ. However, these correlations are low to moderate 
and do not exceed the criterion of conceptual similarity.
W ith respect to generalizability of the present study, 
we believe that the present sample may be an adequate 
reflection of a the D utch population of patien ts w ith 
COPD seen in an ou tpatien t clinic. This sample may 
however not be representative for subgroups of COPD 
such as patients in pulmonary rehabilitation or patients 
w ith  prim ary  co-m orbid ity , w hich were two m ajor 
exclusion criteria.
An im portant clinical implication of the present study 
is that the SGRQ could facilitate the guidance of disease 
management only partially. The SGRQ can only be used 
appropriately for exploring problems in the sub-domains 
Subjective Symptoms and Subjective Im pairm ent, and 
n o t for exploring problem s in  o ther sub-dom ains of 
health status, such as aspects of quality of life.
Most instruments claiming to measure specific aspects 
of health status contain only two to five subscales. Thus, 
at best only some aspects of health status are measured 
by a specific instrum ent. This not only has implications 
for clinical practice, but also for research purposes. In 
pharmacological trials, the drug under study may have 
beneficial effects on some aspects of health status, but 
not on other aspects. If the instrum ents used measure 
only few aspects of health status beneficial effects may 
be missed. W ith  respect to the use of instrum ents in 
clinical practice, the presen t results indicate tha t one 
single instrum ent cannot provide sufficient information 
on a patient's health status to effectively tailor treatm ent 
to the needs of the individual patient, since measuring 
all aspects of health status is a prerequisite for patient- 
tailored treatm ent. This requires com bining different 
instrum en ts in to  a battery  of in strum en ts m easuring 
multiple aspects of health status. However, im plem ent­
ing in strum en ts in daily practice to facilitate disease 
management requires that instrum ents are not too time 
consum ing. The past decade a few sho rt instrum ents 
have been developed specifically to allow m easurem ent 
of health  sta tu s aspects in  rou tine  care, such as the
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Table 3 Correlations between the St George's Respiratory Questionnaire and the Nijmegen Integral Assessment 
Framework#
St George's Respiratory Questionnaire
Symptoms Activity Impacts Total
Nijmegen Integral Assessment Framework 
Symptoms
Subjective Sym ptom s 0.70’ 0.64 0.60 0.74’
Dyspnea Emotions 0.25 0.31 0.32 0.35
Dyspnea Expected 0.43 0.59 0.43 0.57
Fatigue 0.47 0.57 0.60 0.65
Functional Impairment
A ctu a lPh ys ica lA c tiv ity — 0.42 0.31 0.34
Behavio ra lI impairment 0.28 0.65 0.54 0.61
Subjective Impairment 0.67 0.70 0.71 0.81
Quality of Life
G enera lQ u ality  o f Life 0.50 0.46 0.52 0.57
Health-related Quality of Life 0.43 0.42 0.46 0.51
Satisfaction Relations 0.24 — — 0.21
#only significant correlations (p < 0.01) are shown; ^Pearson's r > 0.70 (criterion for conceptual similarity)
Clinical COPD Questionnaire [28], the Respiratory Ill­
ness Q uestionnaire-m onitoring 10 [29], and the Euro- 
QoL [30]. None of these instrum ents provide a detailed 
picture of a patient's health status. Recently, we devel­
oped the N ijm egen C linical Screening In s tru m en t 
(NCSI), an in stru m en t w hich can be used in rou tine  
care [31]. The NCSI is based on the NIAF and measures 
eleven sub-domains of physiological functioning, symp­
tom s, functional im pairm ent, and quality of life. The 
NCSI enables a quick (15-25 m inutes) and detailed  
assessment of health status. Also, the COPD Assessment 
T est (CAT) was developed [32], 'a  validated  sh o rt 
and sim ple in s tru m en t for assessing the  im pact of 
COPD on health status'. The CAT is constructed as a 
uni-dim ensional instrum ent, i.e. m easuring one single 
concept, as expressed in a single score. In addition, the 
correlation between the CAT and the SGRQ-C was well 
above the criterion for conceptual similarity (r = 0.80)
[32]. Taken together, it is very likely that the CAT, like 
the SGRQ, measures illness perceptions. How important 
illness perceptions may be, patient-tailored  treatm ent 
requires a detailed assessment of many aspects of health
status. Therefore, the CAT also will have limited value 
in patient-tailored treatment.
Conclusions
Detailed m easurem ent of health status in patients with 
COPD is a prerequisite for patient-tailored treatm ent. 
However, carefulness should be no ted  w hen selecting 
in strum en ts to m easure health  status, because m ost 
instrum ents measure only a few aspects of health status. 
The SGRQ can only be used appropriately for measuring 
problems in the sub-dom ains Subjective Symptoms and 
Subjective Impairment, and not for measuring problems 
in other sub-domains of health status, such as aspects of 
Quality of Life. Different instruments should be combined 
to provide a detailed picture of a patient's health status.
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